4534.T
Mochida Pharmaceutical Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 3,285.00
+0.15%Year over year
Reported trailing growth
- Revenue
- +6.2%
- EBITDA
- —
- EBIT
- +15.9%
- EPS
- +12.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.2%
- EBITDA
- —
- EPS
- +30.8%
Three-year CAGR
- Revenue
- -1.5%
- EBITDA
- -13.5%
- EBIT
- -17.3%
- Net income
- -18.7%
- EPS
- -16.7%
- Free cash flow
- +17.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026